Evidence map›Paper›PMID 35277397›Full record

ArticleBMJ open2022

Histopathological profile of cervical biopsies in northern Malawi: a retrospective cross-sectional study.

Paul Uchizi Kaseka, Alfred Kayira, Chikondi Sharon Chimbatata, Master R O Chisale, Pocha Kamudumuli, Tsung-Shu Joseph Wu, Balwani Chingatichifwe Mbakaya, Frank Watson Sinyiza

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Paul Uchizi KasekaPaediatrics Department, Mzuzu Central Hospital, Mzuzu, Malawi kasekapaul2016@gmail.com.ORCID 0000-0002-6651-8000
Alfred KayiraLaboratory Department, Mzuzu Central Hospital, Mzuzu, Malawi.
Chikondi Sharon ChimbatataPaediatrics Department, Mzuzu Central Hospital, Mzuzu, Malawi.
Master R O ChisaleBiological Sciences, Mzuzu University, Mzuzu, Malawi.ORCID 0000-0002-8301-6184
Pocha KamudumuliLaboratory, University of Maryland and Global Initiative Company, Lilongwe, Malawi.
Tsung-Shu Joseph WuResearch, Ping Tung Christian Hospital, Pingtung, Taiwan.
Balwani Chingatichifwe MbakayaPublic Health, University of Livingstonia, Mzuzu, Malawi.ORCID 0000-0002-4705-9064
Frank Watson SinyizaClinical Department, Mzuzu Central Hospital, Mzuzu, Malawi.
Mzuzu University · MWPingtung Christian Hospital · TWUniversity of Livingstonia · MW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAccording to the WHO (2014), cervical cancer is the second most common cancer in women globally. More than 85% of the global cervical cancer morbidity and mortality occur in low-income and middle-income countries and the highest risk region is in Eastern and Southern Africa. Malawi has the highest age-standardised rate of cervical cancer in the world. This study was carried out to determine the histopathological profile of cervical biopsies in a public tertiary hospital in Mzuzu, northern region of Malawi.

settingA public tertiary hospital in Mzuzu, northern region of Malawi.

participantsThis was a retrospective study of all cervical biopsy specimen reports received in a public tertiary hospital in northern Malawi over a period of 5 years from July 2013 to June 2018. Demographic, clinical and diagnostic data were obtained from original histopathology reports.

resultsA total of 500 cervical biopsy reports were reviewed during the study period. The mean age of the patients was 41.99±12.5. Age ranged from 15 to 80 years. Cervicitis accounted for 46.0% (n=162) of the total non-malignant lesions seen, followed by cervical intraepithelial neoplasm, at 24.4% (n=86) and endocervical polyp, at 20.5% (n=72). Squamous cell carcinoma (SCC) accounted for 15.6% (n=78) of the total cervical biopsies studied and 85.7% of all total malignant lesions. Adenocarcinoma and undifferentiated carcinoma were 8.8% and 4.4%, respectively of the total malignant diagnosis. All patients with malignant lesions had HIV.

conclusionOur study shows that cervicitis and SCC were most common among non-malignant and malignant cervical biopsies, respectively. Since the frequency of cervical cancer is high, there is a need to have well detailed national policies to be put in place to increase detection of preinvasive lesions in order to reduce the prevalence of cervical cancer.

Indexed as

Carcinoma, Squamous CellUterine Cervical NeoplasmsUterine CervicitisAdolescentAdultAgedAged, 80 and overBiopsyCross-Sectional StudiesFemaleHumansMalawiMiddle AgedRetrospective StudiesYoung Adultcervical biopsiescervical cancercervical intraepithelial neoplasmcervicitismalignant

Identifiers

PMID35277397
PMCPMC8919446
OpenAlexW4220996909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.